Logistic regression analysis indicated that patients with lower expression levels of Cstb had poorer clinicopathological features (e.g., lymph node metastases, perineural invasion, low degree of differentiation, and advanced tumor stage). The gene discussed is CSTB; the disease is neoplasm.